Reference health
High-Energy Ball Milling as Green Process To Vitrify Tadalafil and Improve Bioavailability
29/29 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 29 checked references that resolve
resolves10.1016/j.addr.2016.03.006
Physical chemistry of supersaturated solutions and implications for oral absorption
resolves10.1002/jps.23041
Solid-State Vitrification of Crystalline Griseofulvin by Mechanical Milling
resolves10.1016/j.addr.2016.01.011
Perspectives on the amorphisation/milling relationship in pharmaceutical materials
resolves10.1016/j.addr.2016.01.012
Amorphous solid dispersions: Rational selection of a manufacturing process
resolves10.1021/js9601896
Characteristics and Significance of the Amorphous State in Pharmaceutical Systems
resolves10.1016/j.jconrel.2014.06.059
Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole
resolves10.1016/j.ejpb.2013.03.002
Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension
resolves10.1016/j.ejps.2011.11.025
Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo
resolves10.1016/j.powtec.2015.04.044
Preparation and characterization of solid dispersion using a novel amphiphilic copolymer to enhance dissolution and oral bioavailability of sorafenib
resolves10.1016/j.ejps.2014.05.026
The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil
resolves10.1016/j.ejps.2016.05.007
High energy ball milling and supercritical carbon dioxide impregnation as co-processing methods to improve dissolution of tadalafil
resolves10.1016/j.ijpharm.2012.11.026
Evaluation of gastrointestinal drug supersaturation and precipitation: Strategies and issues
resolves10.1016/j.jconrel.2015.06.004
Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers
resolves10.1016/j.ejps.2013.01.004
The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions
resolves10.1021/mp400439q
Evolution of Supersaturation of Amorphous Pharmaceuticals: The Effect of Rate of Supersaturation Generation
resolves10.1016/j.ijpharm.2012.03.009
Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion
resolves10.1016/j.ijpharm.2012.10.013
Application of mixtures of polymeric carriers for dissolution enhancement of oxeglitazar using hot-melt extrusion
resolves10.1007/s11095-009-0021-1
Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution
resolves10.1021/mp8000793
Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview
resolves10.1002/jps.22643
Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?
resolves10.1002/jps.24493
Adsorption of Polyvinylpyrrolidone and its Impact on Maintenance of Aqueous Supersaturation of Indomethacin via Crystal Growth Inhibition
resolves10.1016/j.bcp.2012.11.020
Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells
resolves10.1016/j.ijpharm.2006.01.020
Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies
resolves10.1016/j.pharmthera.2014.11.013
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
resolves10.1371/journal.pone.0019329
The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter
resolves10.1016/j.biopha.2014.12.028
Soluplus® micelles as a potential drug delivery system for reversal of resistant tumor
The 2 references without a DOI — listed, not checked
no DOI — not checkedSolubility Enhancement with BASF Pharma Polymers, Solubilizer Compendium
no DOI — not checkedWizel, S.; Krochmal, B.; Givant, A.; Diller, D.Tadalafil crystal forms and processes for preparing them. US 2006/0111571 A1.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1021/acs.molpharmaceut.6b00688"><img src="https://citestamp.com/citestamped/10.1021/acs.molpharmaceut.6b00688/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1021/acs.molpharmaceut.6b00688)